Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis.

about

Synchronous Hodgkin lymphoma and gastric adenocarcinoma: A rare case report and literature review.

P2860

Q49636510-24854A7F-B034-4893-8DE5-23C60DC3DBA2

P2860

Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis.

Item

http://www.wikidata.org/entity/Q36936841

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Second malignancies after auto ...... tics and risk factor analysis.

@en

type

Item

label

Second malignancies after auto ...... tics and risk factor analysis.

@en

prefLabel

Second malignancies after auto ...... tics and risk factor analysis.

@en

P1476

Second malignancies after auto ...... tics and risk factor analysis.

@en

P2093

Anna Czyż

http://www.w3.org/2001/XMLSchema#string

Anna Lojko-Dankowska

http://www.w3.org/2001/XMLSchema#string

Dominik Dytfeld

http://www.w3.org/2001/XMLSchema#string

Maciej Kaźmierczak

http://www.w3.org/2001/XMLSchema#string

Magdalena Matuszak

http://www.w3.org/2001/XMLSchema#string

Mieczysław Komarnicki

http://www.w3.org/2001/XMLSchema#string

P2860

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy

Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.

Second acute leukemia and other malignancies following treatment for Hodgkin's disease.

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.

Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.

P304

200-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2013.34626

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240310313

http://www.w3.org/2001/XMLSchema#string

P698

23788991

http://www.w3.org/2001/XMLSchema#string

P932

3685379

http://www.w3.org/2001/XMLSchema#string

Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis.

about

P2860

P2860

Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932